Profiles: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 15: | Line 15: | ||
==See Also== | ==See Also== | ||
*[[How to use QIBA Profiles]] | *[[How to use QIBA Profiles]] | ||
*[[QIBA Profile Template]] | *[[QIBA Profile Template]] shows the structure, rationale and content of a Profile (show All Markup to see guidance in the Word comments) | ||
*[[Committees]] lists Biomarker Committees developing profiles which may link to DRAFT documents in progress for the next stage. | *[[Committees]] lists Biomarker Committees developing profiles which may link to DRAFT documents in progress for the next stage. | ||
*[[Profile Conformance]] describes how sites and products claim conformance to a Profile. | *[[Profile Conformance]] describes how sites and products claim conformance to a Profile. | ||
Revision as of 20:39, 16 November 2016
Profiles published here have completed one of the QIBA Profile Stages of development and been approved by their Biomarker Committee.
Stage 3: Technically Confirmed
Stage 2: Consensus (Publicly Reviewed)
Stage 1: Public Comment
- DCE-MRI Quantification 2011-12-13 (Public Comment ended Feb 2012)
- CT Volumetry for Advanced Disease 2011-07-08 (Public Comment ended Sept 2011)
See Also
- How to use QIBA Profiles
- QIBA Profile Template shows the structure, rationale and content of a Profile (show All Markup to see guidance in the Word comments)
- Committees lists Biomarker Committees developing profiles which may link to DRAFT documents in progress for the next stage.
- Profile Conformance describes how sites and products claim conformance to a Profile.